Presence of Well-Funded Research Organizations to Retain North America’s Dominance in Vocal Biomarker Market
According to recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease diagnostics including psychiatric and cardiovascular ailments. Post-successful execution of clinical trials, HIPAA-compliant vocal biomarkers are set to serve as effective alternatives to currently available disease diagnostic systems such as CT scan, MRI and X-ray.
Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example, Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 million samples of voice in more than 40 different languages.
Site Management by CROs Essential for Ensuring Vocal Biomarker Clinical Trails’ Success
Contract research organizations (CROs) are likely to spearhead the global vocal biomarker market, in terms of revenues as well as growth rate. Given the expanding range of voice-assistant, health-related applications, life sciences, and healthcare organizations have commenced designing an array of scenarios to deploy voice assistant platforms in clinical trial settings. The integration of these platforms in the research for vocal biomarkers has the potential to address specific drawbacks in a current clinical trial environment.
CROs are essential and play a key role in ensuring the clinical trials’ success through proper site management. Accurate level of site management & oversight prompts site to effectively recruit, train, and retain subjects, meanwhile ensuring overall management of subjects, protocol adherence, and regulatory compliance. CROs help in maintaining and improving the communication flow, thereby reducing protocol deviations & violations, and addressing data issues & queries. These benefits of CROs also effectively apply to the quality and integrity of clinical trials apropos of vocal biomarkers.
Non-invasiveness of Vocal Biomarker in Psychiatric Disorder Diagnostics in Sync with Self-diagnosis’ Upward Trend
Sound vibrations have been employed as biomarkers for diagnosing psychiatric disorders such as depression and anxiety. Similar distinctive features, known as vocal biomarkers, have been recently discovered by scientists that might pose a massive influence on developing a diagnostic tool. Additionally, latest research analyses have greatly impacted application of vocal biomarkers in diagnosing psychiatric ailments ranging from stress to Parkinson’s disease.
Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impractical for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders. Moreover, these significant user-friendly tools fall perfectly in line with the upward trend of self-diagnosis, which in turn has considerably fuelled their demand across the globe. Psychiatric disorders are likely to remain the leading indication in the global vocal biomarker market, with revenues estimated to rake in approximately $130 million by 2027-end.
North America Vocal Biomarker Market: Driven by Government Agencies’ Tie-ups with Voice-Related Companies
Robust healthcare infrastructure, and presence of well-funded research organizations equipped with cutting-edge technologies in North America have made the region a lucrative breeding place for vocal biomarkers. Tie-ups of the U.S. government agencies with voice-based companies and analysis researchers is a primary demand determinant for vocal biomarkers in the region across areas such as geriatrics and war-induced trauma. For example, the U.S. Army entered into a collaboration with researchers from MIT for developing voice-based detection system to diagnose brain injuries.
Sonde Health gains a voice survey and data acquisition platform with its acquisition of NeuroLex.
Social analytics solution redefines social listening with advanced capabilities that marry earned sentiment with organic and paid performance.
OneCause says it will improve customer experience and contact center efficiency with Talkdesk for Salesforce integration, providing actionable insights for support agents through unified customer database.
Clean Call adaptive robocall blocking uses artificial intelligence and voice biometric technology to learn, adapt and beat robocallers at their own game.
Satisfi Labs' Knowledge Management Platform receives investment from the Google Assistant for the growth of Google Actions and to support the voice ecosystem.
Powered by Rev's proprietary speech engine, the Rev.ai API makes it easy for developers to build speech recognition directly into applications and services. The new capability processes live audio or video .
It's now possible to detect everything from depression to Parkinson's disease with speech analytics, but privacy concerns are still being dealt with